Novonesis
404.10 DKK
-1.70 %
Less than 1K followers
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
-1.70 %
-0.91 %
+0.85 %
-0.96 %
-8.90 %
-1.85 %
+14.83 %
+13.32 %
+992.16 %
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Read moreMarket cap
189.24B DKK
Turnover
283.99M DKK
Revenue
28.59B
EBIT %
13.07 %
P/E
80.87
Dividend yield-%
1.03 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
25.2
2026
Annual report '25
23.3
2026
General meeting '26
All
Research
Press releases
ShowingAll content types
HCA 2025 forudsigelser - Ramte lidt uden for skiven
HCA Morgenbørs 28/11 - Små stigninger i futures og fokus på kursmålsændringer
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools




